Cure My Disease

Don't miss your cure!

 Log in / Sign up

Steady steps: could targeted balance training shield diabetic seniors from falls?

NCT ID NCT07786194

Disease control Sponsor: Universiteit Antwerpen Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 25, 2026 · Last updated Aug 26, 2026 · Updated 1 time

Summary

This study tests whether a 12-week exercise program, with or without added balance exercises, can improve balance and touch/vibration sensation in adults aged 60 and older with type 2 diabetes. Participants are randomly assigned to either standard exercise plus balance training or standard exercise plus relaxation exercises. The goal is to see if targeted balance work can reduce fall risk and improve diabetes-related health measures.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A 12-week exercise program with or without additional balance exercises, delivered at home with an activity tracker and supervised sessions.
What this could lead to
If effective, this approach could reduce fall risk and improve quality of life for older adults with type 2 diabetes.
What could go wrong
The trial is small and early, and results may not apply to all people with diabetes. Balance improvements may not translate to fewer falls in real life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 48 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2025

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of type 2 diabetes mellitus * Age 60 years or older * Both men and women * Impaired balance control identified during the testing procedure for balance control, defined as a score of less than 30 seconds on the Standing on Foam with Eyes Closed test and/or less than 10 seconds on the Single Leg Stance with Eyes Open test * Able to understand the Dutch language. Exclusion Criteria: * A history of central neurological disease including stroke, multiple sclerosis, Parkinson's disease, dementia or intracranial tumor * Severe visual impairment such as blindness, cataract or glaucoma * Physical impairment which would preclude subjects from participating in an exercise /physical activity program (e.g. orthopedic conditions, severe cardiac conditions, uncontrolled hypertension etc.) * Need of physical or material support * HbA1c \< 7.5% (- the aim is to include patients with an HbA1c of \<7.5%, but if the treating endocrinologist considers an HbA1c value of 7.5 - 8% desirable for medical reasons, this patient will still be included) * Use of medication that can affect balance (e.g. sedatives, antidepressants, or antipsychotics) * Not understanding the Dutch language

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Balance control in elderly are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Motor Activity Somatosensory Disorders type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Balance control in elderly Diabetes mellitus, type 2 Impaired balance in elderly Somatosensory disorders

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Universiteit Antwerpen

    RECRUITING

    Edegem, Antwerpen, 2650, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.